228 related articles for article (PubMed ID: 27639968)
1. Molecular imaging of the extracellular matrix in the context of atherosclerosis.
Reimann C; Brangsch J; Colletini F; Walter T; Hamm B; Botnar RM; Makowski MR
Adv Drug Deliv Rev; 2017 Apr; 113():49-60. PubMed ID: 27639968
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
4. Collagen and related extracellular matrix proteins in atherosclerotic plaque development.
Shami A; Gonçalves I; Hultgårdh-Nilsson A
Curr Opin Lipidol; 2014 Oct; 25(5):394-9. PubMed ID: 25137612
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z
Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
7. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
[TBL] [Abstract][Full Text] [Related]
8. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
9. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
Zhao ZM; Qin SC
Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix: paving the way to the newest trends in atherosclerosis.
Gialeli C; Shami A; Gonçalves I
Curr Opin Lipidol; 2021 Oct; 32(5):277-285. PubMed ID: 34320563
[TBL] [Abstract][Full Text] [Related]
11. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
[TBL] [Abstract][Full Text] [Related]
12. Imaging of atherosclerosis: can molecular imaging do more?
Lairez O; Fayad ZA
Arch Cardiovasc Dis; 2013 Nov; 106(11):551-3. PubMed ID: 23927996
[No Abstract] [Full Text] [Related]
13. Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers.
Zan C; An J; Wu Z; Li S
Nanotheranostics; 2023; 7(3):327-344. PubMed ID: 37064609
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of atherosclerosis by imaging.
Ibañez B; Badimon JJ; Garcia MJ
Am J Med; 2009 Jan; 122(1 Suppl):S15-25. PubMed ID: 19110084
[TBL] [Abstract][Full Text] [Related]
15. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.
Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.
Kowara M; Cudnoch-Jedrzejewska A; Opolski G; Wlodarski P
Clin Exp Pharmacol Physiol; 2017 Jul; 44(7):711-718. PubMed ID: 28440887
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
Wang X; Peter K
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
[TBL] [Abstract][Full Text] [Related]
18. Imaging atherosclerosis and vulnerable plaque.
Sadeghi MM; Glover DK; Lanza GM; Fayad ZA; Johnson LL
J Nucl Med; 2010 May; 51 Suppl 1(Suppl 1):51S-65S. PubMed ID: 20395341
[TBL] [Abstract][Full Text] [Related]
19. Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers.
Wang X; Nai YH; Gan J; Lian CPL; Ryan FK; Tan FSL; Chan DYS; Ng JJ; Lo ZJ; Chong TT; Hausenloy DJ
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446302
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
McAteer MA; Choudhury RP
Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
